---
figid: PMC2828057__nihms171785f1
figtitle: Genetic factors influencing cytarabine therapy
organisms:
- Mus musculus
- Rattus norvegicus
- Cricetulus griseus
- Homo sapiens
- Saccharomyces cerevisiae
pmcid: PMC2828057
filename: nihms171785f1.jpg
figlink: /pmc/articles/PMC2828057/figure/F1/
number: F1
caption: 'Key candidate genes involved in the metabolic activation of ara-C are shown.
  DCK and hENT1 are favorable for therapeutic efficacy of ara-C and other nucleoside
  analogs and CDA, DCTD and NT5C2 are not.Ara-C: Cytarabine; CDA: Cytidine deaminase;
  DCK: Deoxycytidine kinase; DCTD: Deoxycytidylate deaminase; NT5C2: 5´nucleotidase.'
papertitle: Genetic factors influencing cytarabine therapy.
reftext: Jatinder K Lamba. Pharmacogenomics. ;10(10):1657-1674.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9703579
figid_alias: PMC2828057__F1
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
- Cricetulus griseus
redirect_from: /figures/PMC2828057__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2828057__nihms171785f1.html
  '@type': Dataset
  description: 'Key candidate genes involved in the metabolic activation of ara-C
    are shown. DCK and hENT1 are favorable for therapeutic efficacy of ara-C and other
    nucleoside analogs and CDA, DCTD and NT5C2 are not.Ara-C: Cytarabine; CDA: Cytidine
    deaminase; DCK: Deoxycytidine kinase; DCTD: Deoxycytidylate deaminase; NT5C2:
    5´nucleotidase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cda
  - Nt5c2
  - Dck
  - Dctd
  - Cux1
  - Rrm2
  - Rrm1
  - Parva
  - SLC29A1
  - CDA
  - NT5C2
  - DCK
  - DCTD
  - CUX1
  - NPPA
  - RRM2
  - RRM1
  - Ara-CTP
  - Ara-U
  - Ara-C
  - Ara-CDP
  - CDP
  - Nucleoside diphosphate
  - Ribonucleotide
  - Ara-UMP
---
